1 completed, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow AGN 194204: new trials by email Literature Review of AGN 194204 trials Research Report on AGN 194204
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of IRX4204 for Treatment of Early Parkinson's Disease IRX4204 - Parkinson's Disease | Phase 1 | Completed | Io Therapeutics | 15 | 2014-08-01 | 2015-05-12 |
| Oral NRX 194204 in Patients With Refractory Malignancies NRX 194204 - Refractory Malignancies | Phase 1 | Terminated | University of Southern California | 24 | 2008-02-01 | 2014-05-21 |
Neoplasms (1) · Parkinson Disease (1)
Io Therapeutics (1) · University of Southern California (1)
United States (2)
Ken Marek, MD (1)